Observational studyMicrobiologyOpen2026
Oral Microbial and Metabolic Alterations in Patients With Oral Lichen Planus Concomitant With Type 2 Diabetes Mellitus.
Observational study in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The present study aimed to comprehensively characterize the oral microbiome and metabolic profiles in patients with oral lichen planus (OLP) concomitant with type 2 diabetes mellitus (T2DM), and to explore the potential mechanisms driving the co-occurrence. This was a cross-sectional observational study. A total of 60 participants were enrolled, including 20 normal controls, 20 patients with OLP alone (OLP group), and 20 patients with both OLP and T2DM (OLP_DM group). Salivary samples were subjected to 16S rRNA sequencing and untargeted metabolomics to assess microbiological and metabolic differences across the groups. Spearman's correlation analysis was used to evaluate associations between clinical characteristics and microbial or metabolic features. Alpha diversity (Chao1 index) was significantly reduced in both disease groups compared to the controls, while beta diversity analysis revealed no remarkable separation among groups. At the genus level, the abundance of Pseudomonas was elevated in the OLP_DM group relative to both the OLP and control groups, and positively correlated with lesion severity. Metabolomic analysis revealed significantly lower levels of limonin and higher levels of thymine and epinephrine in the OLP_DM group compared to the OLP. Limonin was negatively correlated with lesion severity, whereas thymine and epinephrine showed positive correlations with both lesion severity and pain scores. The study provides comprehensive evidence of oral microbial dysbiosis and metabolic disturbances in patients with OLP concomitant with T2DM. The findings suggest an interplay between specific bacterial populations and metabolic alterations in the progression and severity of OLP concomitant with diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.